Eagle Pharmaceuticals (EGRX) PT Raised to $66 at RBC Capital
Tweet Send to a Friend
RBC Capital analyst Randall Stanicky raised the price target on Eagle Pharmaceuticals (NASDAQ: EGRX) to $66.00 (from $64.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
